BTX-2541

N/A

Report date: 2025/05/27 11:03:00

NME

Base Information

Drug NameBTX-2541

Drug Alias NameBTX-2541

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionProteolysisV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors

TargetsGTPase KRas

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiotheryx Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiotheryx Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A